Trending stocks: Cadila Healthcare shares flat ahead of Q4 results
A total of 28,973 shares changed hands on the counter till 10:36AM (IST).
By ETMarkets.com | Updated:
BCCL
Total market cap of the Cadila Healthcare Ltd. stood at Rs 37622.54 crore at the time of writing this report.
NEW DELHI: Shares of Cadila Healthcare Ltd. traded 0.03 per cent down in Friday's trade at 10:36AM (IST). Around 28,973 shares changed hands on the counter.
The stock opened at Rs 370.0 and touched an intraday high and low of Rs 370.0 and Rs 364.7, respectively, in the session so far. The stock of Cadila Healthcare Ltd. quoted a 52-week high of Rs 383.65 and a 52-week low of Rs 206.45.
Total market cap of the Cadila Healthcare Ltd. stood at Rs 37622.54 crore at the time of writing this report.
Cadila Healthcare is slated to announce its March quarter earnings on Friday.
Key Financials
The company reported consolidated sales of Rs 3534.5 crore for the quarter ended 31-Dec-2019, up 8.95 per cent from previous quarter's Rs 3244.2 crore and up 0.52 per cent from the year-ago quarter's Rs 3516.1 crore.
Shareholding pattern
As of 31-Mar-2020, domestic institutional investors held 7.33 per cent stake in the firm, while foreign institutional investors held 4.41 per cent and the promoters 74.88 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 30.08 and a price-to-book ratio of 3.22. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Cadila Healthcare Ltd. belongs to the Pharma - Indian industry.
The stock opened at Rs 370.0 and touched an intraday high and low of Rs 370.0 and Rs 364.7, respectively, in the session so far. The stock of Cadila Healthcare Ltd. quoted a 52-week high of Rs 383.65 and a 52-week low of Rs 206.45.
Total market cap of the Cadila Healthcare Ltd. stood at Rs 37622.54 crore at the time of writing this report.
Cadila Healthcare is slated to announce its March quarter earnings on Friday.
Key Financials
The company reported consolidated sales of Rs 3534.5 crore for the quarter ended 31-Dec-2019, up 8.95 per cent from previous quarter's Rs 3244.2 crore and up 0.52 per cent from the year-ago quarter's Rs 3516.1 crore.
ADVERTISEMENT
The net profit for latest quarter stood at Rs 371.4 crore, down 27.28 per cent from the corresponding quarter last year. Shareholding pattern
As of 31-Mar-2020, domestic institutional investors held 7.33 per cent stake in the firm, while foreign institutional investors held 4.41 per cent and the promoters 74.88 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 30.08 and a price-to-book ratio of 3.22. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
ADVERTISEMENT
Cadila Healthcare Ltd. belongs to the Pharma - Indian industry.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
